Amyloid beta peptide (1-42)-mediated antioxidant imbalance is associated with activation of protein kinase C in red blood cells

Cell Biochemistry and Function

Volumn 33, Issue 4, 2015, Pages 196-201

  Carelli Alinovi, Cristiana ^b   Giardina, Bruno ^b,c   Misiti, Francesco ^a  

^a UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CNR   (Italy)

Author keywords

Amyloid beta peptide; Oxidative stress; Pentose phosphate pathway; Protein kinase C; Red blood cell

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; CYTOSKELETON PROTEIN; GLUCOSE; OXYGEN; PROTEIN KINASE C; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ANTIOXIDANT; PEPTIDE FRAGMENT;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE METABOLISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; OXIDATIVE STRESS; OXYGEN TENSION; OXYGENATION; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN PROCESSING; DRUG EFFECTS; GLYCOLYSIS; HUMAN; METABOLISM; PATHOLOGY;

ADENOSINE TRIPHOSPHATE; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; ENZYME ACTIVATION; ERYTHROCYTES; GLUCOSE; GLYCOLYSIS; HUMANS; OXIDATIVE STRESS; PENTOSE PHOSPHATE PATHWAY; PEPTIDE FRAGMENTS; PROTEIN KINASE C;

EID: 84931561012     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3103     Document Type: Article

References (37)

1. Butterfield DA. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 2002; 36: 1307-13. Review.
2. Butterfield DA, Swomley AM, Sultana R. Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal 2013; 19: 823-35.
3. Misiti F, Clementi ME, Giardina B. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide (1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function. Neurochem Int 2010; 56: 597-602.
4. Chen M, Inestrosa GS, Rosy HL, Fernandez HL. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Comun 1995; 213: 96-103.
5. Seubert P, Vigo-Pelfrey C, Esche F, Lele M, Dove H, David D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992; 359: 325-327.
6. Grammas P, Yamada M, Zlokovic B. The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease. Review J Alzheimers Dis 2002; 4: 217-23.
7. Lan J, Liu J, Zhao Z, et. al. The peripheral blood of Aβ binding RBC as a biomarker for diagnosis of Alzheimer's disease. Age Ageing 2015, [Epub ahead of print].
8. Clementi ME, Martorana GE, Pezzotti M, Giardina B, Misiti F. Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell. Int J Biochem Cell Biol 2004; 36: 2066-2076.
9. Misiti F, Orsini F, Clementi ME, et al. Amyloid peptide inhibits ATP release from human RBCs. Biochem Cell Biol 2008; 86: 501-508.
10. Kosenko EA, Solomadin IN, Tikhonova LA, Ready VP, Aliev G, Kaminsky YG. Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and RBC energy metabolism. CNS Neurol Disord Drug Targets 2014; 13: 112-119.
11. Jayakumar R, Kusiak JW, Chrest FJ, Femehin AA, Murali J, West RP. Red cell perturbations by amyloid beta-protein. Biochim Biophys Acta 2003; 1622: 20-28.
12. Misiti F, Carelli-Alinovi C, Sampaolese B, Giardina B. β-amyloid decreases detectable endothelial nitric oxide synthase in human RBCs: a role for membrane acetylcholinesterase. Cell Biochem Funct 2012; 30: 474-479.
13. Clementi ME, Giardina B, Colucci D, Galtieri A, Misiti F. Amyloid-beta peptide affects the oxygen dependence of RBC metabolism: a role for caspase 3. Int J Biochem Cell Biol 2007; 39: 727-735.
14. Mandal D, Baudin-Creuza V, Bhattacharyya A, et al. Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3). J Biol Chem 2003; 278: 52551-52558.
15. Jenkins JD, Kezdy FJ, Steck TL. Mode of interaction of phosphor-fructokinase with the RBC membrane. J Biol Chem 1985; 260: 10426-10433.
16. 2-linked transition of hemoglobin. FEBS Lett 1996; 390: 25-28.
17. Nicolay JP, Liebig G, Niemoeller OM, et al. Inhibition of suicidal RBC death by nitric oxide. Pflugers Archi 2008; 456: 293-305.
18. Govekar RB, Zingde SM. Protein kinase C isoforms in human RBCs. Ann Hematol 2001; 80: 531-534.
19. Cohen CM, Gascard P. Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins. Semin Hematol 1992; 29: 244-292.
20. Park IC, Park MJ, Rhee CH, et al. Protein kinase C activation by PMA rapidly induces apoptosis through caspase-3/CPP32 and serine protease(s) in a gastric cancer cell line. Int J Oncol 2001; 18: 1077-10783.
21. Klarl BA, Lang PA, Kempe DS, et al. Protein kinase C mediates RBC "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006; 290: 244-253.
22. Zijlstra WG, Buursma A, Meeuwsen-van der Roest WP. Absorption spectra of human fetal and adult oxyhemoglobin, de-oxyhemoglobin, carboxyhemoglobin, and methemoglobin. Clin Chem 1991; 37: 1633-1638.
23. Misiti F, Meucci E, Zuppi C, et al. O(2)-dependent stimulation of the pentose phosphate pathway by S-nitrosocysteine in human RBC. Biochemical and Biophyical Research Communications 2002; 294: 829-834.
24. Barvitenko NN, Adragna NC, Weber RE. RBC signal transduction pathways, their oxygenation dependence and functional significance. Cell Physiol Biochem 2005; 15: 1-18.
25. Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Comun 2002; 293: 1566-1570.
26. Danilov YN, Cohen CM. Wheat germ agglutinin but not concanavalin A modulates protein kinase C-mediated phosphorylation of red cell skeletal proteins. FEBS Lett 1989; 257: 431-434.
27. George A, Pushkaran S, Konstantinidis DG, et al. RBC NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease. Blood 2013; 121: 2099-2107.
28. Low PS, Rathinavelu P, Harrison ML. Regulation of glycolysis via reversible enzyme binding to the membrane protein, band 3. J Biol Chem 1993; 268: 14627-31.
29. Nicolay JP, Gatez S, Liebig G, Gulbins E, Lang F. Amyloid induced suicidal RBC death. Cell Physiol Biochem 2007; 19: 175-184.
30. de Oliveira S, Silva-Herdade AS, Saldanha C. Modulation of RBC deformability by PKC activity. Clin Hemorheol Microcirc 2008; 39: 363-373.
31. Kansha M, Takeshige K, Minakami S. Decrease in the phosphotyrosine phosphatase activity in the plasma membrane of human neutrophils on stimulation by phorbol 12-myristate 13-acetate. Biochim Biophys Acta 1993; 1179: 189-196.
32. Borowski P, Heiland M, Kornetzky L, Medem S, Laufs R. Purification of catalytic domain of rat spleen p72syk kinase and its phosphorylation and activation by protein kinase C. Biochem J 1998; 331: 649-657.
33. Garton AJ, Tonks NK. PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. EMBO J 1994; 13: 3763-3771.
34. Low PS, Allen DP, Zioncheck TF, et al. Tyrosine phosphorylation of band 3 inhibits peripheral protein binding. J Biol Chem 1987; 262: 4592-4596.
35. Kosenko EA, Aliev G, Tikhonova LA, Li Y, Poghosyan AC, Kaminsky YG. Antioxidant status and energy state of RBCs in Alzheimer dementia: probing for markers. CNS Neurol Disord Drug Targets 2012; 11: 926-32.
36. Carelli-Alinovi C, Pirolli D, Giardina B, Misiti F. Protein kinase C mediates caspase 3 activation: a role for RBC morphology changes. Clin Hemorheol Microcirc 2014; in press.
37. Mohanty JG, Eckley DM, Williamson JD, Launer LJ, Rifkind JM. Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease? Adv Exp Med Biol 2008; 614: 29-35.